Literature DB >> 14617014

Long-term safety and feasibility of arteriovenous fistulae as vascular accesses in children with haemophilia: a prospective study.

Elena Santagostino1, Alessandro Gringeri, Luisa Berardinelli, Claudio Beretta, Myrvet Muça-Perja, Pier Mannuccio Mannucci.   

Abstract

Infectious and thrombotic complications limit the long-term use of subcutaneous ports as venous accesses for children with haemophilia. This study has evaluated for the first time the safety and feasibility of internal arteriovenous fistulae (AVF) as alternative accesses. During the 3-year study period, 27 severe haemophiliacs, 14 with factor VIII inhibitors (52%), underwent the creation of 31 proximal AVF in the forearm. Mild forearm haematomas were observed after five procedures (16%) in five patients who had or developed inhibitors after surgery. Inadequate AVF maturation was observed after five of 31 procedures (16%) in four children. AVF were first accessed after a median of 42 d and regularly used at home by 26 patients (96%) for a median follow-up period of 29 months. Thrombosis of a venous branch occurred in one AVF (3%) after 9 months of uncomplicated use in a child with inhibitor who spontaneously recovered from the symptoms and still used AVF for nine additional months. Mild symptoms, referable to distal ischaemia, were transiently reported by two children (7%) who needed no remedial intervention. This study demonstrates that the use of AVF in haemophiliacs enabled long-term treatment at home in all patients but one.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617014     DOI: 10.1046/j.1365-2141.2003.04632.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

Review 1.  Barriers to primary prophylaxis in haemophilic children: the issue of the venous access.

Authors:  Elena Santagostino; Maria Elisa Mancuso
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

Review 2.  Management of haemophilia A-inhibitor patients: clinical and regulatory perspectives.

Authors:  Zera Tellier; Marie-Hélène André; Benoît Polack
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

3.  Improved treatment feasibility in children with hemophilia using arteriovenous fistulae: the results after seven years of follow-up.

Authors:  Maria Elisa Mancuso; Luisa Berardinelli; Claudio Beretta; Mauro Raiteri; Ermanno Pozzoli; Elena Santagostino
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

Review 4.  Past, present and future of hemophilia: a narrative review.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Orphanet J Rare Dis       Date:  2012-05-02       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.